Summary
Synovial fluids and sera from patients with rheumatoid arthritis, psoriatic arthritis, yersinia arthritis, Behçet's syndrome, Crohn's disease, and osteoarthritis were tested for antinuclear antibodies and antibodies to five cytoskeletal components in sensitive enzyme-linked immunosorbent assay (ELISA) systems and for IL-6 concentrations in a proliferation assay (IL-6 dependent hybridoma cell line B13.29, subclone B9). Statistically significant correlations between antibody activities and IL-6 levels were found for vimentin antibodies (r= 0.56; p<0.05) and actin antibodies (r= 0.44;p<0.05). In patients with chronic and active disease like rheumatoid arthritis and psoriatic arthritis, optical densities measured by vimentin- and actin-ELISA were significantly different from those measured in patients with osteoarthritis. To date only a few reports exist concerning the incidence of antibodies in synovial fluids. We have shown to our knowledge for the first time that IL-6 seems to induce synovial fluid antibody activities restricted to cytoskeletal components of synoviocytes (i.e., vimentin and actin). Synovial fluid antibody activities against vimentin and actin appear to be markers of activity in patients with inflammatory joint disease.
Similar content being viewed by others
Abbreviations
- ELISA:
-
enzyme-linked immunosorbent assay
- ANA:
-
antinuclear antibodies
- ACA:
-
antibodies against cytoplasmic components
- RA:
-
rheumatoid arthritis
- OA:
-
osteoarthritis
- SF:
-
synovial fluid
- RF:
-
rheumatoid factors
- FCS:
-
fetal calf serum
- IFT:
-
immunofluorescence microscopy
- PBS:
-
phosphate buffered saline
- BSA:
-
bovine serum albumin
- OD:
-
optical density
- SLE:
-
systemic lupus erythematosus
- IL-6:
-
interleukin-6
- HGF:
-
hybridoma growth factor
- BSF-2:
-
B-cell-stimulatory factor
- DMEM:
-
Dulbecco's modified Eagles Medium
References
Aarden LA, De Groot ER, Schaap OL (1987) Production of hybridoma growth factor by human monocytes. Eur J Immunol 17:1411–1416
Abrahamsen TG, Froland SS, Natvig JB (1975) Elution and characterization of lymphocytes from rheumatoid inflammatory tissue. Scand J Immunol 4:823–830
Al-Balaghi S, Strom H, Moller E (1984) B cell differentiation factor in synovial fluid of patients with rheumatoid arthritis. Immunol Rev 78:7–23
Clague RB, Moore LJ (1984) IgG and IgM antibody to native type II collagen in rheumatoid arthritis serum and synovial fluid. Evidence for the presence of collagen-anticollagen immune complexes in synovial fluid. Arthritis Rheum 27:1370–1377
Egeland T, Lea T, Saari G, Mellbye OJ, Natvig JB (1982) Quantitation of cells secreting rheumatoid factors of IgG, IgA and IgM class after elution from rheumatoid synovial tissue. Arthritis Rheum 25:1445–1450
Fay AC, Trudgett A, McCrea JD (1958) Detection and partial characterization of human B cell colony stimulating activity in synovial fluids of patients with rheumatoid arthritis. Clin Exp Immunol 60:316–322
Hermann E, Fleischer B, Mayet WJ, Poralla T, Meyer zum Büschenfelde KH (1989) Correlation of synovial fluid interleukin 6 (IL-6) activities with IgG concentrations in patients with inflammatory joint disease and osteoarthritis. Clin Exp Rheumatol 7:411–414
Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y (1986) Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324:73–76
Hollywell C, Morris CJ, Farr M, Walton KW (1983) Ultra-structure of synovial changes in rheumatoid disease and in seronegative inflammatory arthropathies. Virchows Arch (Pathol Anat) 400:345–355
Houssiau FA, Devogelaer JP, van Damme J, Nagant de Deuxchaisnes C, van Snick J (1988) Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 31:784–787
Kirstein H, Hjarvard K, Hansen TM (1989) Antikeratin antibodies in synovial fluid in rheumatoid arthritis. APMIS 97:185–189
Kitani A, Hara M, Hirose T (1987) Synovial fluids from patients with rheumatoid arthritis possess B cell differentiation activity contributing to synthesis of rheumatoid factor in vitro. J Rheumatol 14:873–879
Koopman WJ, Schrohenloher RE, Crago SS, Spalding DM, Mestecky J (1985) IgA rheumatoid factor synthesis by dissociated synovial cells. Characterization and relationship to IgM rheumatoid factor synthesis. Arthritis Rheum 28:1219–1227
Mayet WJ, Hess G, Gerken G, Rossol S, Voth R, Manns M, Meyer zum Büschenfelde KH (1989) Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. Hepatology 10:24–28
Meyer O, Semmache M, Cyna J, Mitrovic D, Ryckewaert A (1983) Les anticorps anticollagene. Detection au cours de la polyarthrite rhumatoide, de la polychondrite chronique atrophiante et de divers rhumatismes inflammatoires chroniques. Rev Rhum Mal Osteoartic 50:493–499
Munthe E, Natvig JB (1972) Complement fixing intracellular complexes of IgG rheumatoid factor in rheumatoid plasma cells. Scand J Immunol 1:217–229
Niebauer GW, Wolf B, Bashey RI, Newton CD (1987) Antibodies to canine collagen types I and II in dogs with spontaneous cruciate ligament rupture and osteoarthritis. Arthritis Rheum 30:319–327
Petersen J, Ingemann-Hansen T, Halkjaer-Kristensen J (1984) Spontaneous and induced immunoglobulin secretion by synovial fluid B lymphocytes in rheumatoid arthritis. Ann Rheum Dis 43:140–145
Pollard KM, Murphy LJ, Webb J (1988) Anti-Sm and anti-DNA antibodies in paired serum and synovial fluid samples from patients with SLE. Rheumatol Int 8:197–204
Rowley MJ, Williamson DJ, Mackay IR (1987) Evidence for local synthesis of antibodies to denatured collagen in the synovium in rheumatoid arthritis. Arthritis Rheum 30:1420–1425
Sabharval UK, Vaughan JH, Fong S (1982) Activation by the classical pathway of complement by rheumatoid factors. Assessment by radioimmunoassay for C4. Arthritis Rheum 25:161–167
Singer II, Kazazis DM, Kawka DW, Rupp EA, Bayne EK (1985) Extracellular matrix interactions in rheumatoid arthritis. Arthritis Rheum 28:1105–1116
Smiley J, Sachs C, Ziff M (1968) In vitro synthesis of immunoglobulin by rheumatoid synovial membrane. J Clin Invest 47:624–632
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
Van Boxel JA, Paget SA (1975) Predominantly T cell infiltrate in rheumatoid synovial membranes. N Engl J Med 293:517–520
Wood DD, Ihrie EJ, Hamerman D (1985) Release of interleukin-1 from human synovial tissue in vitro. Arthritis Rheum 28:853–861
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mayet, W.J., Hermann, E., Bachmann, M. et al. Correlation of anti-cytoskeleton antibody activities in synovial fluid with interleukin-6 in patients with osteoarthritis and inflammatory joint disease. Klin Wochenschr 68, 685–691 (1990). https://doi.org/10.1007/BF01667017
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01667017